Insider · CIK 0001304773
Alan W Dunton
Files at PTN (PALATIN TECHNOLOGIES INC), OGEN (ORAGENICS INC), CRMD (CorMedix Inc.). First filing Dec 9, 2024, latest Jan 2, 2026.
Where the trades landed
Last year at the 3 companies this insider has traded most, with each buy and sell on the bar it happened.
CRMD: CorMedix Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
PTN: PALATIN TECHNOLOGIES INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
OGEN: ORAGENICS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | CorMedix Inc. | $260k 20,000 shares | -33% | +113% from low-25% from high | |
| 31Weak | CorMedix Inc. | $131k 10,000 shares | -20% | +121% from low-22% from high | |
| 50Moderate | PALATIN TECHNOLOGIES INC | $4.0M 200 shares | +0% | - | |
| 23Weak | ORAGENICS INC | $24 66 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 6, 2024 | OGEN ORAGENICS INC | 66 0.00% of outstanding | $22 | Dec 6, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | CRMD CorMedix Inc. | AGrant or award Common Stock | +30,453 | $0.00 | $0 | 70,703 | Jan 27, 2026 |
| Dec 30, 2025 | CRMD CorMedix Inc. | MOption exercise Common Stock10b5-1 | +20,000 | $4.03 | $81k | 60,250 | Jan 2, 2026 |
| Dec 30, 2025 | CRMD CorMedix Inc. | SOpen-market sale Common Stock10b5-1 | -20,000 | $13.00 | $260k | 40,250 | Jan 2, 2026 |
| Dec 30, 2025 | CRMD CorMedix Inc. | MOption exercise Stock Option (Right to Buy Common Stock)derivative10b5-1 | -20,000 | $0.00 | $0 | 0 | Jan 2, 2026 |
| Dec 11, 2025 | OGEN ORAGENICS INC | AGrant or award Non-Employee Director Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Dec 15, 2025 |
| Dec 9, 2025 | PTN PALATIN TECHNOLOGIES INC | AGrant or award Common Stock10b5-1 | +1,000 | $0.00 | $0 | 13,081 | Dec 11, 2025 |
| Dec 9, 2025 | PTN PALATIN TECHNOLOGIES INC | AGrant or award Common Stock10b5-1 | +1,000 | $0.00 | $0 | 14,081 | Dec 11, 2025 |
| Dec 9, 2025 | PTN PALATIN TECHNOLOGIES INC | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +1,200 | $0.00 | $0 | 24,799 | Dec 11, 2025 |
| Dec 9, 2025 | PTN PALATIN TECHNOLOGIES INC | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +1,200 | $0.00 | $0 | 25,999 | Dec 11, 2025 |
| Sep 12, 2025 | CRMD CorMedix Inc. | MOption exercise Common Stock | +10,000 | $3.55 | $36k | 50,250 | Sep 16, 2025 |
| Sep 12, 2025 | CRMD CorMedix Inc. | SOpen-market sale Common Stock | -10,000 | $13.13 | $131k | 40,250 | Sep 16, 2025 |
| Sep 12, 2025 | CRMD CorMedix Inc. | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -10,000 | $0.00 | $0 | 20,000 | Sep 16, 2025 |
| Jun 13, 2025 | PTN PALATIN TECHNOLOGIES INC | POpen-market purchase Series D Preferred Stock | +200 | $20,000.00 | $4.0M | 224,112 | Jun 17, 2025 |
| Jun 13, 2025 | PTN PALATIN TECHNOLOGIES INC | POpen-market purchase Series I warrantsderivative | +363,636 | $0.00 | $0 | 420,016 | Jun 17, 2025 |
| Jan 17, 2025 | CRMD CorMedix Inc. | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 40,250 | Jan 22, 2025 |
| Dec 6, 2024 | OGEN ORAGENICS INC | SOpen-market sale Common Stock | -66 | $0.36 | $24 | 25,623 | Dec 9, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.